Literature DB >> 28123618

Comparison of neurological clinical manifestation in patients with hemorrhagic and ischemic stroke.

Seyedhossein Ojaghihaghighi1, Samad Shams Vahdati2, Akram Mikaeilpour3, Ali Ramouz4.   

Abstract

BACKGROUND: Cerebrovascular accident (CVA) is the third leading cause of death and disability in developed countries. Anyone suspected of having a stroke should be taken immediately to a medical facility for diagnosis and treatment. The symptoms that follow a stroke aren't significant and depend on the area of the brain that has been affected and the amount of tissue damaged. Parameters for predicting long-term outcome in such patients have not been clearly delineated, therefore the aim of this study was to investigate this possibility and to test a system that might practicably be used routinely to aid management and predict outcomes of individual stroke patients.
METHODS: A descriptive hospital-based study of the neurological symptoms and signs of 503 patients with ischemic stroke, including severe headache, seizure, eye movement disorder, pupil size, Glasgow Coma Scale (GCS), agitation were analyzed in this study.
RESULTS: In the current study, dilated pupils, agitation, acute onset headache, lower GCS score, seizure, and eye gaze impairment had significantly higher prevalence in hemorrhagic stroke patients (P<0.001). However, the rate of gradual progressive headache is significantly higher in ischemic stroke patients (P<0.001).
CONCLUSION: Although this result provides reliable indicators for discrimination of stroke types, imaging studies are still the gold standard modality for diagnosis.

Entities:  

Keywords:  Neurologic manifestations; Statistical model; Stroke

Year:  2017        PMID: 28123618      PMCID: PMC5263033          DOI: 10.5847/wjem.j.1920-8642.2017.01.006

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  19 in total

1.  Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. NINDS tPA Stroke Trial Investigators.

Authors:  P Lyden; M Lu; C Jackson; J Marler; R Kothari; T Brott; J Zivin
Journal:  Stroke       Date:  1999-11       Impact factor: 7.914

2.  Incidence and occurrence of total (first-ever and recurrent) stroke.

Authors:  G R Williams; J G Jiang; D B Matchar; G P Samsa
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

3.  Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials.

Authors:  T J DeGraba; J M Hallenbeck; K D Pettigrew; A J Dutka; B J Kelly
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

4.  Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis.

Authors:  R W Smith; P A Scott; R J Grant; C R Chudnofsky; S M Frederiksen
Journal:  Acad Emerg Med       Date:  1999-06       Impact factor: 3.451

5.  Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy.

Authors:  J C Grotta; D Chiu; M Lu; S Patel; S R Levine; B C Tilley; T G Brott; E C Haley; P D Lyden; R Kothari; M Frankel; C A Lewandowski; R Libman; T Kwiatkowski; J P Broderick; J R Marler; J Corrigan; S Huff; P Mitsias; S Talati; D Tanne
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

Review 6.  Thrombolysis for acute ischaemic stroke.

Authors:  J M Wardlaw; G del Zoppo; T Yamaguchi
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months.

Authors:  P L Kolominsky-Rabas; C Sarti; P U Heuschmann; C Graf; S Siemonsen; B Neundoerfer; A Katalinic; E Lang; K G Gassmann; T R von Stockert
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

8.  The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.

Authors:  J Bogousslavsky; G Van Melle; F Regli
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

9.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

10.  Is it clinically possible to distinguish nonhemorrhagic infarct from hemorrhagic stroke?

Authors:  G Besson; C Robert; M Hommel; J Perret
Journal:  Stroke       Date:  1995-07       Impact factor: 7.914

View more
  25 in total

1.  Strengthening the Case for Cluster Set Resistance Training in Aged and Clinical Settings: Emerging Evidence, Proposed Benefits and Suggestions.

Authors:  Christopher Latella; Carolyn Peddle-McIntyre; Lauren Marcotte; James Steele; Kristina Kendall; Ciaran M Fairman
Journal:  Sports Med       Date:  2021-05-13       Impact factor: 11.136

2.  Paradoxical brain embolism followed by percutaneous atrial septal closure: Stroke in a patient's thirties highlighting some issues surrounding brain stroke in an emergency setting.

Authors:  Daisuke Matsubara; Koichi Kataoka; Teppei Matsubara; Takaomi Minami; Takanori Yamagata
Journal:  World J Emerg Med       Date:  2017

3.  Genetic variants within Ninjurin 2 gene are associated with risk of ischemic stroke in Iranian population.

Authors:  Vadoud Malekzadeh; Iman Azari; Rezvan Noroozi; Roshanak Shams; Mina Farzaneh; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Neurol Sci       Date:  2019-08-02       Impact factor: 3.307

Review 4.  Defining and Managing Pain in Stroke and Traumatic Brain Injury Research.

Authors:  Christina M Larson; George L Wilcox; Carolyn A Fairbanks
Journal:  Comp Med       Date:  2019-12-20       Impact factor: 0.982

5.  Plasma levels of sirtuin-1 in patients with cerebrovascular stroke.

Authors:  Imam M Esmayel; Samia Hussein; Ehab A Gohar; Huda F Ebian; Mayada M Mousa
Journal:  Neurol Sci       Date:  2021-01-28       Impact factor: 3.307

Review 6.  Neuroinflammation and fibrosis in stroke: The good, the bad and the ugly.

Authors:  Narayanappa Amruta; Abir A Rahman; Emmanuel Pinteaux; Gregory Bix
Journal:  J Neuroimmunol       Date:  2020-07-09       Impact factor: 3.478

7.  Factors influencing quality of life in patients followed in the neurosonology laboratory for carotid stenosis.

Authors:  Táňa Fadrná; Zdeňka Mikšová; Roman Herzig; Kateřina Langová; Libor Ličman; David Školoudík
Journal:  Health Qual Life Outcomes       Date:  2018-04-27       Impact factor: 3.186

8.  Glial Fibrillary Acidic Protein Serum Level as a Predictor of Clinical Outcome in Ischemic Stroke.

Authors:  Vivien Puspitasari; Pricilla Yani Gunawan; Hugo Dwiputra Wiradarma; Vinson Hartoyo
Journal:  Open Access Maced J Med Sci       Date:  2019-05-14

9.  Longer length of post-acute care stay causes greater functional improvements in poststroke patients.

Authors:  Yu-Ju Tung; Chin-Tsan Huang; Wen-Chih Lin; Hsin-Han Cheng; Julie Chi Chow; Chung-Han Ho; Willy Chou
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

10.  Comparison of Ischemic and Hemorrhagic Stroke in the Medical Ward of Dessie Referral Hospital, Northeast Ethiopia: A Retrospective Study.

Authors:  Hussen Abdu; Fentaw Tadese; Girma Seyoum
Journal:  Neurol Res Int       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.